Cite

HARVARD Citation

    Benjo, A. et al. (2014). Cilostazol increases patency and reduces adverse outcomes in percutaneous femoropopliteal revascularisation: a meta-analysis of randomised controlled trials. Open heart. 1 (1), p. . [Online]. 
  
Back to record